Nuclear Medicine Market Report

Europe Nuclear Medicine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 14, 2019
  • PAGES：215
  • REPORT CODE：GMM378842
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Nuclear Medicine market was valued at 6600 Million US$ in 2018 and is projected to reach 14565 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.40% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Nuclear Medicine Market Segmentations:

    By Player:

    • Bayer Healthcare

    • NTP Radioisotopes S.A.

    • Ashby Gorman Baker Ltd

    • Sinotau Pharmaceuticals S.P.A

    • Eczcibasi-Monrol Nuclear Products

    • Digirad

    • Advanced Accelerator Applications

    • Nordion

    • GE Healthcare, Inc.

    • Curium

    • Philips Healthcare

    • Mallinckrodt PLC

    • Siemens Healthcare

    • IBA Molecular Imaging

    • Mediso Ltd.

    By Type:

    • Therapeutic

    • Diagnostic

    By End-User:

    • Cardiology

    • Neurology

    • Oncology

    • Thyroid

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Nuclear Medicine Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • 1.3.2 Europe Nuclear Medicine Market Size and Growth Rate of Diagnostic from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Nuclear Medicine Market Size and Growth Rate of Cardiology from 2014 to 2026

    • 1.4.2 Europe Nuclear Medicine Market Size and Growth Rate of Neurology from 2014 to 2026

    • 1.4.3 Europe Nuclear Medicine Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.4 Europe Nuclear Medicine Market Size and Growth Rate of Thyroid from 2014 to 2026

    • 1.4.5 Europe Nuclear Medicine Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Nuclear Medicine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine by Major Types

      • 3.4.1 Market Size and Growth Rate of Therapeutic

      • 3.4.2 Market Size and Growth Rate of Diagnostic

    4 Segmentation of Nuclear Medicine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nuclear Medicine for Cardiology

      • 4.4.2 Market Size and Growth Rate of Nuclear Medicine for Neurology

      • 4.4.3 Market Size and Growth Rate of Nuclear Medicine for Oncology

      • 4.4.4 Market Size and Growth Rate of Nuclear Medicine for Thyroid

      • 4.4.5 Market Size and Growth Rate of Nuclear Medicine for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Nuclear Medicine Production Analysis by Top Regions

    • 5.2 Europe Nuclear Medicine Consumption Analysis by Top Regions

    • 5.3 Europe Nuclear Medicine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Nuclear Medicine Market among Top Countries

    • 6.1 Top 5 Export Countries in Nuclear Medicine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Nuclear Medicine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Nuclear Medicine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Nuclear Medicine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Nuclear Medicine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Nuclear Medicine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Nuclear Medicine Landscape Analysis

    • 7.1 Germany Nuclear Medicine Landscape Analysis by Major Types

    • 7.2 Germany Nuclear Medicine Landscape Analysis by Major End-Users

    8. UK Nuclear Medicine Landscape Analysis

    • 8.1 UK Nuclear Medicine Landscape Analysis by Major Types

    • 8.2 UK Nuclear Medicine Landscape Analysis by Major End-Users

    9. France Nuclear Medicine Landscape Analysis

    • 9.1 France Nuclear Medicine Landscape Analysis by Major Types

    • 9.2 France Nuclear Medicine Landscape Analysis by Major End-Users

    10. Italy Nuclear Medicine Landscape Analysis

    • 10.1 Italy Nuclear Medicine Landscape Analysis by Major Types

    • 10.2 Italy Nuclear Medicine Landscape Analysis by Major End-Users

    11. Spain Nuclear Medicine Landscape Analysis

    • 11.1 Spain Nuclear Medicine Landscape Analysis by Major Types

    • 11.2 Spain Nuclear Medicine Landscape Analysis by Major End-Users

    12. Poland Nuclear Medicine Landscape Analysis

    • 12.1 Poland Nuclear Medicine Landscape Analysis by Major Types

    • 12.2 Poland Nuclear Medicine Landscape Analysis by Major End-Users

    13. Russia Nuclear Medicine Landscape Analysis

    • 13.1 Russia Nuclear Medicine Landscape Analysis by Major Types

    • 13.2 Russia Nuclear Medicine Landscape Analysis by Major End-Users

    14. Switzerland Nuclear Medicine Landscape Analysis

    • 14.1 Switzerland Nuclear Medicine Landscape Analysis by Major Types

    • 14.2 Switzerland Nuclear Medicine Landscape Analysis by Major End-Users

    15. Turkey Nuclear Medicine Landscape Analysis

    • 15.1 Turkey Nuclear Medicine Landscape Analysis by Major Types

    • 15.2 Turkey Nuclear Medicine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Nuclear Medicine Market Volume and Growth Rate

      • 16.3.2 Finland Nuclear Medicine Market Volume and Growth Rate

      • 16.3.3 Norway Nuclear Medicine Market Volume and Growth Rate

      • 16.3.4 Sweden Nuclear Medicine Market Volume and Growth Rate

      • 16.3.6 Iceland Nuclear Medicine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Nuclear Medicine Market Volume and Growth Rate

      • 17.3.2 Netherlands Nuclear Medicine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Nuclear Medicine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Nuclear Medicine Market Volume and Growth Rate

      • 18.3.2 Latvia Nuclear Medicine Market Volume and Growth Rate

      • 18.3.3 Lithuania Nuclear Medicine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Bayer Healthcare

      • 19.1.1 Bayer Healthcare Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 NTP Radioisotopes S.A.

      • 19.2.1 NTP Radioisotopes S.A. Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Ashby Gorman Baker Ltd

      • 19.3.1 Ashby Gorman Baker Ltd Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Sinotau Pharmaceuticals S.P.A

      • 19.4.1 Sinotau Pharmaceuticals S.P.A Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Eczcibasi-Monrol Nuclear Products

      • 19.5.1 Eczcibasi-Monrol Nuclear Products Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Digirad

      • 19.6.1 Digirad Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Advanced Accelerator Applications

      • 19.7.1 Advanced Accelerator Applications Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Nordion

      • 19.8.1 Nordion Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 GE Healthcare, Inc.

      • 19.9.1 GE Healthcare, Inc. Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Curium

      • 19.10.1 Curium Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Philips Healthcare

      • 19.11.1 Philips Healthcare Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Mallinckrodt PLC

      • 19.12.1 Mallinckrodt PLC Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Siemens Healthcare

      • 19.13.1 Siemens Healthcare Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 IBA Molecular Imaging

      • 19.14.1 IBA Molecular Imaging Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Mediso Ltd.

      • 19.15.1 Mediso Ltd. Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 78 Figures and 144 Tables)

    • Figure Product Picture

    • Figure Europe Nuclear Medicine Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • Figure Europe Nuclear Medicine Market Size and Growth Rate of Diagnostic from 2014 to 2026

    • Figure Europe Nuclear Medicine Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Europe Nuclear Medicine Market Size and Growth Rate of Neurology from 2014 to 2026

    • Figure Europe Nuclear Medicine Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Europe Nuclear Medicine Market Size and Growth Rate of Thyroid from 2014 to 2026

    • Figure Europe Nuclear Medicine Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure France Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Nuclear Medicine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine by Different Types from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Therapeutic

    • Figure Market Size and Growth Rate of Diagnostic

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Cardiology

    • Figure Market Size and Growth Rate of Neurology

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Thyroid

    • Figure Market Size and Growth Rate of Others

    • Table Europe Nuclear Medicine Production by Major Regions

    • Table Europe Nuclear Medicine Production Share by Major Regions

    • Figure Europe Nuclear Medicine Production Share by Major Countries and Regions in 2014

    • Table Europe Nuclear Medicine Consumption by Major Regions

    • Table Europe Nuclear Medicine Consumption Share by Major Regions

    • Table Germany Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table UK Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table France Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table Italy Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table Spain Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table Poland Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table Russia Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table Switzerland Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table Turkey Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Nuclear Medicine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Nuclear Medicine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Nuclear Medicine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Germany Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table Germany Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Germany Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table UK Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table UK Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table UK Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table UK Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table France Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table France Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table France Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table France Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Italy Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table Italy Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Italy Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Spain Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table Spain Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Spain Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Poland Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table Poland Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Poland Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Russia Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table Russia Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Russia Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Switzerland Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Turkey Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table Turkey Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Turkey Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Nuclear Medicine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Bayer Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Healthcare

    • Figure Sales and Growth Rate Analysis of Bayer Healthcare

    • Figure Revenue and Market Share Analysis of Bayer Healthcare

    • Table Product and Service Introduction of Bayer Healthcare

    • Table Company Profile and Development Status of NTP Radioisotopes S.A.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NTP Radioisotopes S.A.

    • Figure Sales and Growth Rate Analysis of NTP Radioisotopes S.A.

    • Figure Revenue and Market Share Analysis of NTP Radioisotopes S.A.

    • Table Product and Service Introduction of NTP Radioisotopes S.A.

    • Table Company Profile and Development Status of Ashby Gorman Baker Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ashby Gorman Baker Ltd

    • Figure Sales and Growth Rate Analysis of Ashby Gorman Baker Ltd

    • Figure Revenue and Market Share Analysis of Ashby Gorman Baker Ltd

    • Table Product and Service Introduction of Ashby Gorman Baker Ltd

    • Table Company Profile and Development Status of Sinotau Pharmaceuticals S.P.A

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sinotau Pharmaceuticals S.P.A

    • Figure Sales and Growth Rate Analysis of Sinotau Pharmaceuticals S.P.A

    • Figure Revenue and Market Share Analysis of Sinotau Pharmaceuticals S.P.A

    • Table Product and Service Introduction of Sinotau Pharmaceuticals S.P.A

    • Table Company Profile and Development Status of Eczcibasi-Monrol Nuclear Products

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eczcibasi-Monrol Nuclear Products

    • Figure Sales and Growth Rate Analysis of Eczcibasi-Monrol Nuclear Products

    • Figure Revenue and Market Share Analysis of Eczcibasi-Monrol Nuclear Products

    • Table Product and Service Introduction of Eczcibasi-Monrol Nuclear Products

    • Table Company Profile and Development Status of Digirad

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Digirad

    • Figure Sales and Growth Rate Analysis of Digirad

    • Figure Revenue and Market Share Analysis of Digirad

    • Table Product and Service Introduction of Digirad

    • Table Company Profile and Development Status of Advanced Accelerator Applications

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Accelerator Applications

    • Figure Sales and Growth Rate Analysis of Advanced Accelerator Applications

    • Figure Revenue and Market Share Analysis of Advanced Accelerator Applications

    • Table Product and Service Introduction of Advanced Accelerator Applications

    • Table Company Profile and Development Status of Nordion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion

    • Figure Sales and Growth Rate Analysis of Nordion

    • Figure Revenue and Market Share Analysis of Nordion

    • Table Product and Service Introduction of Nordion

    • Table Company Profile and Development Status of GE Healthcare, Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare, Inc.

    • Figure Sales and Growth Rate Analysis of GE Healthcare, Inc.

    • Figure Revenue and Market Share Analysis of GE Healthcare, Inc.

    • Table Product and Service Introduction of GE Healthcare, Inc.

    • Table Company Profile and Development Status of Curium

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curium

    • Figure Sales and Growth Rate Analysis of Curium

    • Figure Revenue and Market Share Analysis of Curium

    • Table Product and Service Introduction of Curium

    • Table Company Profile and Development Status of Philips Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Philips Healthcare

    • Figure Sales and Growth Rate Analysis of Philips Healthcare

    • Figure Revenue and Market Share Analysis of Philips Healthcare

    • Table Product and Service Introduction of Philips Healthcare

    • Table Company Profile and Development Status of Mallinckrodt PLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt PLC

    • Figure Sales and Growth Rate Analysis of Mallinckrodt PLC

    • Figure Revenue and Market Share Analysis of Mallinckrodt PLC

    • Table Product and Service Introduction of Mallinckrodt PLC

    • Table Company Profile and Development Status of Siemens Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare

    • Figure Sales and Growth Rate Analysis of Siemens Healthcare

    • Figure Revenue and Market Share Analysis of Siemens Healthcare

    • Table Product and Service Introduction of Siemens Healthcare

    • Table Company Profile and Development Status of IBA Molecular Imaging

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBA Molecular Imaging

    • Figure Sales and Growth Rate Analysis of IBA Molecular Imaging

    • Figure Revenue and Market Share Analysis of IBA Molecular Imaging

    • Table Product and Service Introduction of IBA Molecular Imaging

    • Table Company Profile and Development Status of Mediso Ltd.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mediso Ltd.

    • Figure Sales and Growth Rate Analysis of Mediso Ltd.

    • Figure Revenue and Market Share Analysis of Mediso Ltd.

    • Table Product and Service Introduction of Mediso Ltd.

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US